Ma, Xun
Zhou, Ping
Kugelmass, Adin
Toskic, Denis
Warner, Melissa
Lee, Lisa
Fogaren, Terry
Godara, Amandeep
Wang, Ming
Li, Yamin
Yang, Liu
Xu, Qiaobing
Comenzo, Raymond L.
Article History
Received: 23 October 2018
Revised: 1 February 2019
Accepted: 11 March 2019
First Online: 29 March 2019
Compliance with ethical standards
:
: Drs Comenzo, Ma, and Zhou have a patent on the siRNA sequences used to knock down expression of the κ light chain constant region. Dr Comenzo has served as a consultant or advisor to Takeda Millennium, Unum, Prothena and Janssen, and has received clinical research funding from Takeda Millennium, Janssen, and Prothena Biotech. Drs Xu and Wang have numerous patents on nanostructure delivery vehicles. The remaining authors declare that they have no conflict of interest.